NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Nov. 7, 2022 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that the company’s management will participate in the BioFuture Conference being held on November 7-9, 2022 at the Lotte New York Palace in New York City, NY.

Kira Sheinerman, Ph.D., Co-Founder and Executive Director, will be a participant in the panel discussion, “New approvals, new approaches, new diagnostics, and can we really reverse the progression of AD?” at 10:30 am EST on Wednesday, November 9th in Holmes I. The panel discussion will focus on the role of new diagnostics tools and novel therapeutics in revolutionizing care for Alzheimer’s patients.